Table 4 Donor-and genotype-related conditioning regimens in SCID.
MSD/MRDc | MUD/MMUD/MMFDc | |
---|---|---|
JAK3, IL2Rγ (T-B+NK-) | Noa/C/D | C/D |
RAG1/2, DCLRE1Cb (T-B-NK+) | C/D | C/D |
IL7Rα, CD3 δ,ε,ζ, CD45 (T-, B+, NK+) | Noa/C/D | C/D |
ADA | Noa/C/D | C/D |
AK2 | C/D | C/D |
MSD/MRDc | MUD/MMUD/MMFDc | |
---|---|---|
JAK3, IL2Rγ (T-B+NK-) | Noa/C/D | C/D |
RAG1/2, DCLRE1Cb (T-B-NK+) | C/D | C/D |
IL7Rα, CD3 δ,ε,ζ, CD45 (T-, B+, NK+) | Noa/C/D | C/D |
ADA | Noa/C/D | C/D |
AK2 | C/D | C/D |